“ADHD Diagnosis and Beyond”

Hazell Webinars

“ADHD Diagnosis and Beyond”

24 24 people viewed this event.


Dr Ute Liersch – Accredited and Chartered Counselling and Coaching Psychologist at The Soke

I’m Dr. Ute, a neurodiverse psychologist who loves blending professionalism with a touch of fun. When I’m not counselling or coaching, I’m on stage as a public speaker, lecturer, and even an amateur stand-up comedian. My journey has taken me from working in hotels across the world to running a private school in Germany to psychology.


According to the National Institute for Care and Health (NIHR), ADHD diagnosis has a 20-fold increase, and ADHD prescription has a 50-fold increase in men between the ages of 18 and 29. In a systematic scoping review of 334 published studies in children and adolescents, Katy Bell et al. (2021) argue that ADHD is over-diagnosed in children and adolescents. For individuals with milder symptoms in particular, the harms associated with an ADHD diagnosis can outweigh the benefits. For adults with a diagnosis of ADHD, drug treatment is predominately the treatment of choice, as it is currently seen as the most effective. However, Meppelink et al. (2016) established that medication can have only short-term effects, treatment adherence is often low, and patients usually feel uncomfortable with the severe side effects they encounter.

The above describes the dilemma faced by those who have contact with clients who might need an ADHD diagnosis. If they are diagnosed, the question arises how to treat this population best.


This talk will show how The Soke has created a diagnostic exclusion pathway to not create false positives. After the diagnosis, the patient has a choice: drug intervention, behavioural intervention or both. Shrestha et al. (2020) state that many studies have shown that nonpharmacological interventions are helpful to the overall management of ADHD. Emotional and behavioural change therapy is essential as many adults with ADHD have comorbidity with other mental health conditions. For example, an estimated 50% of adults with ADHD suffer from anxiety disorder (Publishing, 2022). Affected adults must work harder on their self-esteem as many experience a chronic sense of failure (Ramsay & Rostain, 2005). The Soke offers a multimodal intervention, as evidence and clinical expertise are required for this treatment pathway for ADHD.

This webinar will explore:

  • Diagnostic pathway
  • The psychological impact of ADHD traits and its effect on a functional life
  • Criteria for a functional ADHD behavioural change intervention

Event registration closed.

Date And Time

10-07-24 - 04:00 PM to
10-07-24 - 05:00 PM

Registration End Date



Online event

Event Types

Share With Friends